Dr Reddy's Laboratories gets USFDA nod for generic version of Suboxone

The company, which is launching the product in the US, said approval has been granted in the strengths of 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg.

Source: The Economic Times Healthcare and Biotech News - June 15, 2018 Category: Pharmaceuticals Source Type: news